4//SEC Filing
SHARMA TOM 4
Accession 0001842718-23-000028
CIK 0001842718other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 4:46 PM ET
Size
8.6 KB
Accession
0001842718-23-000028
Insider Transaction Report
Form 4
SHARMA TOM
Chief Product Officer
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2023-04-27$8.58/sh+9,204$78,970→ 9,204 total - Sale
Common Stock, $0.001 par value
2023-04-27$16.00/sh−9,204$147,264→ 0 total - Exercise/Conversion
Options (Right to Buy)
2023-04-27−9,204→ 209,493 totalExercise: $8.58Exp: 2030-11-02→ Common Stock, $0.001 par value (9,204 underlying)
Footnotes (2)
- [F1]The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Such Rule 10b5-1 trading plan was adopted on December 15, 2022.
- [F2]These options were granted on November 2, 2020 and vest 25% after one year and in equal quarterly installments over the next three years.
Documents
Issuer
INTEGRAL AD SCIENCE HOLDING CORP.
CIK 0001842718
Entity typeother
Related Parties
1- filerCIK 0001861730
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 4:46 PM ET
- Size
- 8.6 KB